Literature DB >> 33658638

Genetic diversity and co-prevalence of ESBLs and PMQR genes among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae isolates causing urinary tract infection.

Yilin Xiong1, Cong Zhang2, Wenting Gao3, Yong Ma3, Qingqing Zhang4, Yuqiao Han1, Shiyu Jiang1, Zinan Zhao1, Jia Wang1, Yang Chen5.   

Abstract

Klebsiella pneumoniae is an opportunistic pathogen that frequently causes nosocomial urinary tract infection (UTI). The aim of this study was to investigate the prevalence of extended-spectrum β-lactamases (ESBL), plasmid-mediated quinolone resistance (PMQR) genes, in acquired AmpC (ac-AmpC) β‑lactamase‑producing K. pneumoniae isolates from patients with nosocomial UTI and to characterize the transmissibility of plasmids harbouring multiple resistance genes. From January 2017 to June 2018, we collected 46 ac-AmpC-producing K. pneumoniae isolates causing UTI from a tertiary care hospital in China. Antimicrobial susceptibility assays showed that non-susceptibility of all isolates to third-generation cephalosporin and fluoroquinolone was very high (>80%). Diverse types of ESBLs and PMQR genes, including blaSHV-12 (n = 23), blaSHV-27 (n = 1), blaSHV-28 (n = 2), blaSHV-33 (n = 4), blaCTX-M-3 (n = 24), blaCTX-M-14 (n = 6), blaCTX-M-15 (n = 6), blaCTX-M-22 (n = 1) and blaOXA-10 (n = 26), as well as qnrA (n = 2), qnrB (n = 39) and qnrS (n = 2) genes were identified amongst AmpC-producing K. pneumoniae isolates. The blaAmpC, qnrB and several ESBLs genes from six strains harbouring multiple AmpC (at least two ampC) were co-transferrable to recipients via conjugation or electroporation, with IncFIA, IncFIB and IncA/C being the dominant replicons. Conserved genetic context associated with the mobilization of blaampC genes was detected. Forty-six isolates were categorized into 25 enterobacterial repetitive intergenic consensus (ERIC) types, and the 6 isolates harbouring multiple AmpC genes belonged to ST1 lineage. This work reports that the emergence of plasmids co-harbouring multiple resistance determinants and mediating the local prevalence in K. pneumoniae causing UTI in China.

Entities:  

Year:  2021        PMID: 33658638     DOI: 10.1038/s41429-021-00413-6

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  39 in total

1.  Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.

Authors:  Yoshihiko Maeyama; Yui Taniguchi; Wataru Hayashi; Yusuke Ohsaki; Shunsuke Osaka; Shota Koide; Kiyoko Tamai; Yukiko Nagano; Yoshichika Arakawa; Noriyuki Nagano
Journal:  Vet Microbiol       Date:  2018-02-16       Impact factor: 3.293

Review 2.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

3.  Dynamics of clonal and plasmid backgrounds of Enterobacteriaceae producing acquired AmpC in Portuguese clinical settings over time.

Authors:  T G Ribeiro; Â Novais; C Rodrigues; R Nascimento; F Freitas; E Machado; L Peixe
Journal:  Int J Antimicrob Agents       Date:  2019-03-14       Impact factor: 5.283

Review 4.  beta-Lactamases- the Threat Renews.

Authors:  David M Livermore
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

Review 5.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 6.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

7.  Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.

Authors:  Yi Li; Qing Li; Yuzhen Du; Xiaofei Jiang; Jin Tang; Jianqiang Wang; Guilan Li; Yanqun Jiang
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

8.  Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.

Authors:  Noemí Alonso; Elisenda Miró; Vanesa Pascual; Alba Rivera; Maria Simó; Maria Consol Garcia; Mariona Xercavins; Maria Antonia Morera; Elena Espejo; Mercè Gurguí; Josefa Pérez; Mònica Rodríguez-Carballeira; Javier Garau; Esther Calbo; Ferran Navarro; Beatriz Mirelis; Pere Coll
Journal:  Int J Antimicrob Agents       Date:  2015-11-02       Impact factor: 5.283

9.  Extended-spectrum β-lactamase- and AmpC β-lactamase-producing D-tartrate-positive Salmonella enterica serovar Paratyphi B from broilers and human patients in Belgium, 2008-10.

Authors:  Benoît Doublet; Karine Praud; Tran Nguyen-Ho-Bao; María Angeles Argudín; Sophie Bertrand; Patrick Butaye; Axel Cloeckaert
Journal:  J Antimicrob Chemother       Date:  2013-12-29       Impact factor: 5.790

10.  The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections.

Authors:  Robab Azargun; Mohammad Reza Sadeghi; Mohammad Hossein Soroush Barhaghi; Hossein Samadi Kafil; Fatemeh Yeganeh; Mahin Ahangar Oskouee; Reza Ghotaslou
Journal:  Infect Drug Resist       Date:  2018-07-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.